DTC Guidance Is High Priority In First Amendment Review, FDA Says
Executive Summary
Direct-to-consumer ads are likely to be addressed by FDA early in the upcoming series of First Amendment guidances, Associate Deputy Chief Counsel Seth Ray said during the Food & Drug Law Institute Annual Education Conference in Washington, D.C. April 2
You may also be interested in...
FDA Warns Roche On Xeloda Promotion; Agency Is Keeping Close Eye On Drug
FDA is directing Roche to conduct a broad corrective campaign for the chemotherapy agent Xeloda (capecitabine)
FDA Warns Roche On Xeloda Promotion; Agency Is Keeping Close Eye On Drug
FDA is directing Roche to conduct a broad corrective campaign for the chemotherapy agent Xeloda (capecitabine)
FDA DTC Stance Is “Ideological,” Not Science-Based, Rep. Waxman Says
FDA's "slanted" interpretation of its DTC physician survey results shows the agency is straying from its science-based mission, Rep. Henry Waxman maintains